InvestorsHub Logo
Followers 26
Posts 8986
Boards Moderated 0
Alias Born 12/11/2013

Re: Libtrucker post# 376201

Monday, 09/27/2021 2:45:24 PM

Monday, September 27, 2021 2:45:24 PM

Post# of 403036
There's no mention because IPIX does not have a tablet form currently prepared or from their just completed trial. They've tested B in a small sample see below P1 in 2019....

http://www.ipharminc.com/press-release/2020/1/24/innovation-pharmaceuticals-completes-dosing-in-phase-1-trial-for-new-oral-ulcerative-colitis-drug

http://www.ipharminc.com/press-release/2020/2/13/innovation-pharmaceuticals-phase-1-trial-of-brilacidin-for-ulcerative-colitis-meets-primary-endpoints-positive-topline-results-of-oral-brilacidin




Topline data is expected shortly and includes the safety, tolerability and pharmacokinetics of the Brilacidin tablets. Importantly, the results also include an assessment of the delivery of Brilacidin directly to the colon as determined through gamma scintigraphy.

The Company has partnered with BDD Pharma to utilize their proprietary OralogiK™ technology, an unrivalled erosion-based technology that controls the release of the drug at a pre-defined time. Additional information on this leading technology can be found on the BDD Pharma website.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News